【レポートの概要(一部)】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Pharmaceuticals & Healthcare, Global, Deal Summary 7
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2013 7
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2013 9
2.2.1 Biogen Idec to Acquire Elan’s Interest in Multiple Sclerosis Drug Tysabri for $3.2 Billion 9
2.2.2 Cardinal Health to Acquire AssuraMed for Up to $2.07 Billion 10
2.2.3 Mylan to Acquire Agila Specialties from Strides Arcolab for Up to $1.85 Billion 10
2.2.4 Quintiles Transnational Files Registration Statement for IPO to Raise Up to $600 Million 10
2.2.5 Chiasma Enters into Licensing Agreement with Roche for Octreolin 11
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2013 12
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2013 13
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 14
3.1 Pharmaceuticals & Healthcare, Global, M&A, February 2013 14
3.1.1 Top M&A Deals in February 2013 15
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, September 2012–February 2013 16
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, February 2013 17
3.2.1 Top Equity Offering Deals in February 2013 18
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, September 2012 – February 2013 19
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, February 2013 20
3.3.1 Top PE/VC Deals in February 2013 21
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, February 2013 22
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, February 2013 23
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, September 2012 – February 2013 25
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, September 2012 – February 2013 26
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, February 2013 27
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, September 2012 – February 2013 28
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), February 2013 29
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, February 2013 30
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 31
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, September 2012 – February 2013 32
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), September 2012 – February 2013 33
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), September 2012 – February 2013 34
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2013 35
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), February 2013 36
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, February 2013 37
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, February 2013 37
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, February 2013 38
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), September 2012 – February 2013 39
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 40
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), September 2012 – February 2013 41
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), September 2012 – February 2013 43
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 44
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, February 2013 44
6.1.1 Oncology – Deals of the Month 45
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, February 2013 47
6.2.1 Central Nervous System – Deals of the Month 48
6.3 Pharmaceuticals & Healthcare, Global, Immunology Deals, February 2013 49
6.3.1 Immunology – Deal of the Month 50
6.4 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, February 2013 51
6.4.1 Infectious Diseases – Deals of the Month 52
6.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, February 2013 53
6.5.1 Metabolic Disorders – Deal of the Month 54
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, February 2013 55
6.6.1 Cardiovascular – Deal of the Month 56
6.7 Pharmaceuticals & Healthcare, Global, Respiratory, Deals, February 2013 57
6.7.1 Respiratory – Deal of the Month 58
7 Deal Summary by Geography 59
7.1 Pharmaceuticals & Healthcare, North America Deals, February 2013 59
7.1.1 North America – Deals of the Month 60
7.2 Pharmaceuticals & Healthcare, Europe, Deals, February 2013 62
7.2.1 Europe – Deals of the Month 63
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, February 2013 65
7.3.1 Asia-Pacific – Deals of the Month 66
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, February 2013 67
7.4.1 Rest of the World – Deals of the Month 68
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 69
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, September 2012 – February 2013 69
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, September 2012 – February 2013 70
9 Further Information 71
9.1 Methodology 71
9.2 About GlobalData 71
9.3 Contact Us 72
9.4 Disclosure information 72
9.5 Disclaimer 72
【レポート販売概要】
■ タイトル:事業提携・ライセンシング・投資・M&A動向:February 2013(製薬業界)■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals
■ 発行日:2013年3月12日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160588
■ 調査対象地域:グローバル
- 産業用空気ろ過の世界市場分析:製品別(集塵機、ミストコレクター、HEPAフィルター、カートリッジコレクター・フィルター、バグハウスフィルタ)、エンドユーザー別(セメント、食品、金属、プラスチック、電力)、地域別、セグメント予測、2014-2025The global industrial air filtration market is expected to reach USD 6.08 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand for high-performing, energy-efficient products is expected to catapult the demand over the forecast period. Further, environmental awareness and rapid industrialization coupled with resource scarcity are also expected to catalyze the m …
- 3Dセンサの世界市場:イメージセンサ、ポジションセンサ、加速度計、音響センサThe 3D sensors market is expected to reach USD 5.46 Billion by 2022, at a CAGR of 26.5% between 2016 & 2022. The growth of the market is driven by factors such as the rising demand for 3D-enabled devices in consumer electronics, integration of the optical and electronic components, the use of sensing technology in gaming applications, and the growing requirement for security & surveillance systems …
- ディジタルホログラフィ技術の世界市場の世界市場動向及び予測Digital holography is a 3D technology which produces realistic 3D images of 2D objects with the help of CCD camera. Digital holography is gaining value owing to its growing applications in the medical and retail sectors. The major verticals of this technology such as medical, education, retail, and financial & banking have a large market size in terms of value. The demand for holographic display f …
- 尿検査製品の世界市場:ディップスティック、試薬、尿検査機器、POC検査機器、尿沈渣自動分析装置The urinalysis systems market is expected to reach $1,286 million by 2019 from $892 million in 2014, at a CAGR of 7.6%. The global urinalysis systems market is categorized on the basis of product, test type, application, end user, and region. The disease diagnostics segment is expected to register the highest growth rate in the urinalysis systems market, by application, during the forecast period. …
- 風力タービンピッチシステムの世界市場2019-2023Global Wind Turbine Pitch System Market: About this market A wind turbine pitch system is used to adjust the blade pitch in wind turbines to keep the robot blade moving with the operating limit as the wind speed changes. Technavio’s wind turbine pitch system market analysis considers sales from both onshore and offshore segments. Our analysis also considers the sales of wind turbine pitch system i …
- 2014年戦略提言:Toxoplasmosis診断検査市場The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals &nb …
- マイクロプロセッサ及びGPUの世界市場予測(~2022年)“The global microprocessor and GPU market is expected to grow at a CAGR of 2.2% between 2017 and 2022”The market is expected to be worth USD 83.69 billion by 2022, growing at a CAGR of 2.2% between 2017 and 2022. The growing demand for wearable devices such as smartwatches, migration of data from on-premise environments to cloud-based server environments, and impact of Internet of Things (IoT) are …
- United American Petroleum Corporation:石油・ガスの開発・生産動向及びコスト分析- Q3, 2013United American Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary United American Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. T …
- 世界の連続波発振レーザダイオード市場2015The Global Continuous Wave Laser Diode Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Continuous Wave Laser Diode industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Continuous Wave Laser Diode market analysis is provided for the international mark …
- Japan Pharmaceutical Market Outlook – Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese PlayersJapan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment and Improve the Competitiveness of Japanese Players Summary GBI Research, the leading business intelligence provider, has released its latest research “Japan Pharmaceutical Market Outlook - Deregulation and More Efficient New Drug Approval Process Attract Foreign Investment an …
- 抗体薬物複合体の世界市場及びパイプライン分析Pharmaceutical companies are trying to develop better therapeutics in order to overcome large unmet medical necessities. Currently available therapeutics suffers from various caveats like low specificity, low potency and severe adverse effects. This scenario has caused the pharmaceutical companies to develop therapeutics that can succeed these limitations. They have been able to overcome these pro …
- アジアの気道装置・麻酔装置市場Asia-Pacific Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "Asia-Pacific Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the Asia-Pacific Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, …
- Alliance Oil Company Ltd:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Alliance Oil Company Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Alliance Oil Company Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential …
- 世界の商用航空機用炭素ブレーキ市場動向(2014-2018)About Carbon Brakes Currently, lightweight and fuel-efficient aircraft are in demand. Aircraft manufacturers are endeavoring to make aircraft that meet the requirements of airline companies. Carbon brakes are one of the best substitutes for the traditional steel brakes because they are lightweight and have higher energy consumption capability. Previously, the cost of carbon brakes was high therefo …
- グローバルにおけるX線画像診断機器市場:企業動向MediPoint: Diagnostic X-Ray Imaging - Current and Future Players Summary An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic X-ray imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagnostic X-ra …